Upstate Active Clinical Trials Seeking Participants
Study title
Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First or Second Remission.
IRB number
4429
What is the purpose of the study?
To provide autologous transplantation for patients with acute myeloid leukemia.
Who is eligible?
Diagnosis of acute myeloid leukemia, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction. 18 years to 70 years.
What is involved if I participate?
- How long is the study?
Inpatient stay approximately 21 days, followed for lifetime. - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.
Who is the doctor administering the study?
Teresa C. Gentile, M.D., Ph.D.
Where will the study take place?
SUNY Upstate Medical University,
Syracuse, NY
Over what time period is the study scheduled to run?
06/2001 and continuing
Who can I contact for more information?
- Name: Joanne M. Chilton, CCRP
- Phone: (315) 464-8240
- Email: chiltonj@upstate.edu
- Fax: (315) 464-8274 or (315) 464-8289
If you are interested in this trial, please contact the study coordinator or investigator noted above.
